Xenon Pharmaceuticals Overview
Xenon Pharmaceuticals Target Price
Analysts' 12-month price predictions for XENE.
Share Price
$32.09
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-02-28 | Wedbush | $42 |  30.9% upside |  |
| 2024-10-10 | Raymond JamesDanielle Brill | $50 | 55.8% upside | |
| 2024-10-01 | H.C. WainwrightDouglas Tsao | $53 | 65.2% upside | |
| 2024-08-09 | WedbushLaura Chico | $49 | 52.7% upside | |
| 2024-06-18 | RBC CapitalBrian Abrahams | $55 | 71.4% upside | |
| 2022-12-14 | Goldman Sachs | $60 | 87% upside | |
| 2022-11-28 | Wells Fargo | $50 | 55.8% upside | |
| 2022-11-11 | Guggenheim | $49 | 52.7% upside | |
| 2022-10-18 | Raymond JamesDanielle Brill | $52 | 62% upside | |
| 2022-08-11 | Leerink Partners | $46 | 43.3% upside | |
| 2022-08-10 | RBC Capital | $46 | 43.3% upside | |
| 2022-06-27 | Wedbush | $41 | 27.8% upside | |
| 2022-05-11 | RBC Capital | $41 | 27.8% upside | |